当前位置:Public Access >页面
Chinese/English
Safety and efficacy of histone deacetylase inhibitors (chidamide) in combination with abiraterone in the treatment of metastatic castration-resistant prostate cancer (mCRPC): a single-arm, open phase, Ib clinical study study

ChiCTR注册号:

Reg No. in ChiCTR:

未获得

研究题目:

Safety and efficacy of histone deacetylase inhibitors (chidamide) in combination with abiraterone in the treatment of metastatic castration-resistant prostate cancer (mCRPC): a single-arm, open phase, Ib clinical study study

Study title:

Safety and efficacy of histone deacetylase inhibitors (chidamide) in combination with abiraterone in the treatment of metastatic castration-resistant prostate cancer (mCRPC): a single-arm, open phase, Ib clinical study study

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese clinical trial registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese clinical trial registry

电话:

Telephone:

02087343284

电子邮件

Email

shiyx@sysucc.org.cn

通讯地址:

广东省广州市越秀区东风东路651号

Address:

No.651, Dongfeng East Road, Yuexiu District, Guangzhou, Guangdong Provinve

邮政编码

Postcode

510060

项目负责人所有单位:

Sun yat-sen University Cancer Center

Institution:

Sun yat-sen University Cancer Center

批准本研究的伦理委员会名称:

中山大学肿瘤防治中心

Name of the ethic committee:

Sun yat-sen University Cancer Center

研究疾病:

Study Ailment:

研究所处阶段:

Study phase:

Post-market

研究类型:

Type of Study:

Diagnostic Accuracy Test

研究团队:

Research team:

研究实施地点:

Site of Study:

国家(地区):

省(直辖市):

市(区县):

Country/Area:

Province:

City:

单位
Institution

预计起止时间:

Planned Duration:

2020/8/6 0:00:00-2022/10/12 0:00:00